Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

Winter's chill can wreak havoc on skin, causing acne, dullness, and flare-ups of conditions like eczema. Experts advise ...

Sun Pharma launches Ilumya (Tildrakizumab) in India, expanding its specialty medicines portfolio and bringing advanced ...

North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...

Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of ...

FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

Sun Pharma's managing director, Kirti Ganorkar, said Ilumya is already available in 35 countries and has consistently ...

Sun Pharma introduces ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis treatment. A novel biologic with proven efficacy.

What lies beneath the surface? Ultrasound is revealing the earliest signs of psoriatic arthritis, and changing care in the ...

Jojoba oil has a low comedogenic rating and is light and breathable, which makes it generally well-tolerated by most ...

A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), ...